AETHLON MEDICAL (AEMD) Stock: Buy, Sell, or Hold?
AEMD - AETHLON MEDICAL INC
$5.58
-0.28 (-4.78%)
âŧ
5d:
-8.37%
30d:
+262.34%
90d:
+711.64%
WAIT
LOW Confidence
Analysis Updated: Oct 13, 2026 12:00 AM ET
Earnings: Nov 11, 2026
27d
Get Alerted When AEMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: AEMD is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: AEMD is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: AEMD is currently trading at $5.58, which is considered fair relative to its 30-day fair value range of $2.92 to $7.18.
Technical Outlook: Technically, AEMD is in a strong uptrend. The price is currently testing key support at $5.58. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: AEMD scores 8/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.25 (+137.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AEMD is in a strong uptrend. The price is currently testing key support at $5.58. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: AEMD scores 8/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.25 (+137.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.92 -
$7.18
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
44.7%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (8/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.8%)
- BULLISH: Trading 137.5% below Wall St target ($13.25)
- WARNING: Composite score 34/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.92 -
$7.18
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$5.58
Resistance Level
$6.69
Current Trend
Strong Uptrend
Technical data as of
Oct 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.69
Wall Street Target
$13.25
(+137.5%)
Revenue Growth (YoY)
4278.2%
Share & Embed Analysis
Last updated: October 14, 2026 3:03 AM ET
Data refreshes hourly during market hours. Next update: 4:03 AM
Data refreshes hourly during market hours. Next update: 4:03 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AEMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$60 | 64 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 54 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 64 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 60 BUY |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$104 | 54 HOLD |
